European Journal of Cancer
Volume 38 , Pages 10-14 , February 2002

Clinical experience of capecitabine in metastatic breast cancer

Received 25 June 2001 ,Revised 26 November 2001 ,Accepted 30 November 2001.

References 

  1. Perez EA. Current management of metastatic breast cancer. Semin. Oncol. 1999;26(Suppl. 12):110
  2. Norton L. Salvage chemotherapy of breast cancer. Semin. Oncol. 1994;21(Suppl. 7):1924
  3. Liu G, Franssen E, Fitch M, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J. Clin. Oncol. 1997;15:110–115
  4. Payne SA. A study of quality of life in cancer patients receiving palliative chemotherapy. Soc. Sci. Med. 1992;35:1505–1509
  5. Hansen RM, Ryan L, Anderson T, et al.  Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer. J. Natl. Cancer Inst. 1996;88:668–674
  6. Ragaz J, Campbell C, Gelmon K, Tolcher T, Bryce C, O'Reilly S. Can patients with metastatic breast cancer (MBC) pretreated with cyclophosphamide (C), anthracyclines (A) or Taxol (Tax) respond to infusions of 5-FU (FUI)? Rationale for FUI-containing chemotherapy (CT) regimens. Breast Cancer Res Treat 1997, 46, 95 (abstr 411).
  7. Blum JL, Jones SE, Buzdar AU, et al.  Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J. Clin. Oncol. 1999;17:485–493
  8. Blum JL, Dieras V, LoRusso PM, et al.  Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast cancer patients. Cancer. 2001;92:1759–1768
  9. O'Reilly SM, Moiseyenko V, Talbot DC, Gordon RJ, Griffin T, Osterwalder B. A randomized phase II study of Xeloda™ (capecitabine) vs. paclitaxel in breast cancer patients failing previous anthracycline therapy. Proc Am Soc Clin Oncol 1998, 17, 163a (abstr 627).
  10. O'Shaughnessy J, Blum J, Moiseyenko V, et al.  Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) versus a reference arm of intravenous CMF (cyclophosphamide, methotrexate, 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer. Ann. Oncol. 2001;12:1247–1254

PII: S0959-8049(01)00416-6

European Journal of Cancer
Volume 38 , Pages 10-14 , February 2002

Article Tools

* Image Usage & Resolution